News
News
News
16 May 2023
Azelis strengthens its footprint in life sciences with the acquisition of Gillco Ingredients in the USA
News
2 March 2023
FY2022 results: Strong momentum drives 70% growth in adjusted EBITA
Azelis completes the acquisition of Quimdis News1 September 2021Azelis completes the acquisition of Quimdis
SPI Pharma partners with Azelis Americas in the US and Canada. News3 August 2021SPI Pharma partners with Azelis Americas in the US and Canada.
Azelis expands its pharma and nutraceutical offering to United Kingdom & Ireland News26 July 2021Azelis expands its pharma and nutraceutical offering to United Kingdom & Ireland
Azelis diversifies presence in France and EMEA through the acquisition of Quimdis News20 July 2021Azelis diversifies presence in France and EMEA through the acquisition of Quimdis
Megafarma, an Azelis company, opens a state-of-the-art innovation center in Mexico City with five industry specific laboratories News1 July 2021Megafarma, an Azelis company, opens a state-of-the-art innovation center in Mexico City with five industry specific laboratories
Azelis enables organic growth through the opening of application and training center in Istanbul, Turkey News20 October 2020Azelis enables organic growth through the opening of application and training center in Istanbul, Turkey
Azelis announces mandate extension with Solvay for European pharma markets News22 September 2020Azelis announces mandate extension with Solvay for European pharma markets
Azelis enters into new distribution agreement with GELITA in France News2 September 2020Azelis enters into new distribution agreement with GELITA in France
Azelis India significantly increases its market presence with the acquisition of S. Zhaveri Pharmakem Pvt. Ltd.’s News3 February 2020Azelis India significantly increases its market presence with the acquisition of S. Zhaveri Pharmakem Pvt. Ltd.’s
Azelis closes the acquisition of Megafarma in Mexico News21 January 2020Azelis closes the acquisition of Megafarma in Mexico